Implanet S.A. (ALIMP.PA)
Paris · EUR · Healthcare · Medical Devices
€0.154 (+1.32%) as of
Key statistics
- Market cap
- 22.15M
- EPS (TTM)
- -0.0200
- Dividend yield
- 0.00%
- 52-week range
- 0.1312 – 0.2860
- Beta
- 0.67
- Revenue (TTM)
- 13.8M
- Profit margin
- -32.06%
- Volume
- 26.73k
About Implanet S.A.
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides an ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The company exports its products. Implanet S.A. was founded in 2006 and is headquartered in Martillac, France.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Martillac, France
- Employees
- 49
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.